In the area of BPH/lower urinary tract symptoms, Steven A. Kaplan, MD, pointed to research on minimally invasive therapeutic advances as well as studies on risk factors for LUTS.
“Abstracts this year will focus on advances in minimally invasive therapies for BPH as well as long-term data with the Prostatic Urethral Lift and the GreenLight, holmium, and Thulium lasers,” said Dr. Kaplan, professor of urology at the Icahn School of Medicine at Mount Sinai and director of benign urologic diseases, Mount Sinai Health System, New York.
“A number of presentations will be devoted to risk factors for the development of lower urinary tract symptoms, including obesity, dyslipidemia, and physical activity. Finally, attempts at creating new indices will help us better evaluate, diagnose, and treat men with LUTS,” he added.
Here are Dr. Kaplan's abstract picks from this year's meeting:
PD20-02: Chronic Prostate Inflammation Predicts Symptom Progression in Chronic Prostatitis/Chronic Pelvic Pain Patients
J. Curtis Nickel
PD21-03: Convective Water Vapor Energy (WAVE) Ablation: Two-Year Results Following Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
PD21-06: Mid-term Results using Aquablation, an image guided robot-assisted water jet ablation of the prostate, for the treatment of Benign Prostatic Hyperplasia (BPH).
MP35-03: Lower urinary tract symptoms as risk factor for cardiovascular events in men: a systematic review and meta-analysis of five longitudinal trials
MP35-17: Underactive bladder (UAB) symptoms and voiding parameters in elderly community-dwelling males with 5 year followup